- Home
- ESLT vs ASND Comparison
ESLT vs ASND Comparison
Compare ESLT & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESLT
- ASND
- Stock Information
- Founded
- ESLT 1966
- ASND 2006
- Country
- ESLT Israel
- ASND Denmark
- Employees
- ESLT N/A
- ASND N/A
- Industry
- ESLT Military/Government/Technical
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- ESLT Industrials
- ASND Health Care
- Exchange
- ESLT Nasdaq
- ASND Nasdaq
- Market Cap
- ESLT 8.3B
- ASND 7.7B
- IPO Year
- ESLT 1996
- ASND 2015
- Fundamental
- Price
- ESLT $228.70
- ASND $123.00
- Analyst Decision
- ESLT
- ASND Strong Buy
- Analyst Count
- ESLT 0
- ASND 13
- Target Price
- ESLT N/A
- ASND $195.92
- AVG Volume (30 Days)
- ESLT 23.3K
- ASND 391.4K
- Earning Date
- ESLT 11-26-2024
- ASND 11-05-2024
- Dividend Yield
- ESLT 0.88%
- ASND N/A
- EPS Growth
- ESLT N/A
- ASND N/A
- EPS
- ESLT 5.44
- ASND N/A
- Revenue
- ESLT $6,307,469,000.00
- ASND $340,327,869.00
- Revenue This Year
- ESLT $10.97
- ASND $16.12
- Revenue Next Year
- ESLT $4.93
- ASND $87.44
- P/E Ratio
- ESLT $41.76
- ASND N/A
- Revenue Growth
- ESLT 10.60
- ASND 166.54
- 52 Week Low
- ESLT $175.30
- ASND $86.55
- 52 Week High
- ESLT $229.70
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- ESLT 78.03
- ASND 39.09
- Support Level
- ESLT $207.71
- ASND $124.02
- Resistance Level
- ESLT $229.70
- ASND $133.97
- Average True Range (ATR)
- ESLT 2.08
- ASND 3.67
- MACD
- ESLT 1.71
- ASND -0.33
- Stochastic Oscillator
- ESLT 96.46
- ASND 15.18
About ESLT Elbit Systems Ltd.
Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are used for defense, homeland security, and commercial flight capabilities. Its systems and solutions may be installed on new platforms, or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on the proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company markets its systems and products as a prime contractor or as a subcontractor to government, defense, and homeland security contractors world wide.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.